RPG Group
RPG Group is a diversified conglomerate with operations in infrastructure, tyres, IT, pharmaceuticals, energy, and plantations, generating over $4.4 billion in revenue and operating in more than 135 countries.
Industries of Operation
RPG Group operates in a diverse array of industries. These include infrastructure, tyres, information technology, pharmaceuticals, energy, and plantations. This multi-sectoral presence allows RPG Group to leverage synergies across different businesses and markets. The group's involvement in these varied industries highlights its versatile and wide-reaching economic activities.
Revenue and Global Presence
RPG Group generates over $4.4 billion in revenue. It has built a robust global presence, with operations in over 135 countries. This extensive reach demonstrates the group's ability to scale its operations across different regions and adapt to diverse market needs. The company's significant revenue and international footprint are key indicators of its business success and influence in the global market.
Sustainability and Corporate Social Responsibility
RPG Group is recognized for its commitment to sustainability and corporate social responsibility. This commitment is integrated into its business practices, aiming to create positive impacts on society and the environment. The group's focus on sustainable practices addresses the growing concerns of environmental stewardship and ethical governance in today's corporate landscape.
High-Performance Tyres and Innovation
RPG Group manufactures over 41 million high-performance tyres annually. It is the first tyre company outside Japan to win the prestigious Deming Prize and the first in the world to receive the Lighthouse Designation from the World Economic Forum. The company maintains state-of-the-art R&D centers in India and Germany, emphasizing its focus on innovation and quality in tyre manufacturing.
High-Value Niche APIs
RPG Group offers a range of high-value niche Active Pharmaceutical Ingredients (APIs) for global markets. This product offering underscores the group's capability to cater to specialized demands within the pharmaceutical industry, strengthening its position in the global healthcare sector.